Atrial Fibrillation Trial, Recruiting NCT07428967 Sponsor: St. Josefs-Hospital Wiesbaden GmbH Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT07428967
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have atrial fibrillation (an irregular heartbeat) that causes significant symptoms, and whose condition has not been controlled well enough with standard medications or procedures
  • People whose heart pumping function is within the normal range (confirmed by an ultrasound scan of the heart)
  • People who are already scheduled to have a procedure called AV node ablation, regardless of this study
  • People aged 18 or older
  • People who are able to understand and agree to take part in the study

Who may not be able to join:

  • People whose heart pumping function is below the normal range
  • People who already have a pacemaker implanted
  • People for whom a pacemaker implant or AV node ablation procedure would not be medically appropriate (confirm with trial site for specific details)
  • People with severe disease affecting the valves on the left side of the heart
  • People who have had open-heart bypass surgery in the last 30 days, or who are currently on a specific three-medication blood-thinning regimen following a stent procedure
  • People with a body mass index above 40
  • People who are pregnant
  • People who are not able to provide written consent to participate
  • People whose life expectancy is less than 12 months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
St. Josefs-Hospital Wiesbaden GmbH
Registry
ClinicalTrials.gov
Start date
1 February 2026
Est. completion
31 December 2028

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Number of patients developing pacemaker-induced cardiomyopathy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov